nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes
|
Iacobellis, Gianluca |
|
|
164 |
C |
p. |
artikel |
2 |
Aims and Scope / Editorial Board
|
|
|
|
164 |
C |
p. |
artikel |
3 |
A position statement on screening and management of prediabetes in adults in primary care in Australia
|
Bell, Kirstine |
|
|
164 |
C |
p. |
artikel |
4 |
A systematic review on the safety of Ramadan fasting in high-risk patients with Diabetes
|
Rashid, Fauzia |
|
|
164 |
C |
p. |
artikel |
5 |
Balancing cardiovascular benefit and diabetogenic harm of therapy with statins: Real-world evidence from Italy
|
Corrao, Giovanni |
|
|
164 |
C |
p. |
artikel |
6 |
Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome
|
Avgeris, Margaritis |
|
|
164 |
C |
p. |
artikel |
7 |
Body mass index and mortality among middle-aged Japanese individuals with diagnosed diabetes: The Japan Public Health Center-based prospective study (JPHC study)
|
Yamazaki, Chiho |
|
|
164 |
C |
p. |
artikel |
8 |
Characteristics and outcomes of COVID-19 positive patients with diabetes managed as outpatients
|
Shabto, Julie M. |
|
|
164 |
C |
p. |
artikel |
9 |
Comment on risk factors differ by first manifestation of cardiovascular disease in type 1 diabetes: The impact of microvascular complications
|
Pitocco, Dario |
|
|
164 |
C |
p. |
artikel |
10 |
Comment on “Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?”
|
Cure, Erkan |
|
|
164 |
C |
p. |
artikel |
11 |
Contents
|
|
|
|
164 |
C |
p. |
artikel |
12 |
COVID-19 and diabetes: Is metformin a friend or foe?
|
Ursini, Francesco |
|
|
164 |
C |
p. |
artikel |
13 |
Diabetes care and education training evaluation for General Practitioners and Specialists in Ecuador – Results from needs assessment survey
|
Kaur, Manpreet |
|
|
164 |
C |
p. |
artikel |
14 |
Diabetes mellitus exacerbates citrin deficiency via glucose toxicity
|
Watanabe, Yoriko |
|
|
164 |
C |
p. |
artikel |
15 |
Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus
|
Chee, Ying Jie |
|
|
164 |
C |
p. |
artikel |
16 |
Effect of different exercise training intensities on musculoskeletal and neuropathic pain in inactive individuals with type 2 diabetes – Preliminary randomised controlled trial
|
Cox, Emily R. |
|
|
164 |
C |
p. |
artikel |
17 |
Enhancing resources for healthcare professionals caring for people on intensive insulin therapy: Summary from a national workshop
|
Levine, Brian J. |
|
|
164 |
C |
p. |
artikel |
18 |
Glomerular filtration rate is associated with trabecular bone score in patients with type 2 diabetes mellitus
|
Lamacchia, O. |
|
|
164 |
C |
p. |
artikel |
19 |
Glycemic variability indices determined by self-monitoring of blood glucose are associated with β-cell function in Chinese patients with type 2 diabetes
|
Zhang, Yusheng |
|
|
164 |
C |
p. |
artikel |
20 |
Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients
|
Wang, Zhenzhou |
|
|
164 |
C |
p. |
artikel |
21 |
Is diagnosis of type 2 diabetes a “teachable moment”? A qualitative study
|
Dimova, Elena Dimcheva |
|
|
164 |
C |
p. |
artikel |
22 |
Is DPP4 inhibition a comrade or adversary in COVID-19 infection
|
Dalan, Rinkoo |
|
|
164 |
C |
p. |
artikel |
23 |
Lack of type 1 diabetes involvement in SARS-COV-2 population: Only a particular coincidence?
|
Pitocco, Dario |
|
|
164 |
C |
p. |
artikel |
24 |
Meta-analysis of average change in laboratory-measured HbA1c among people with type 1 diabetes mellitus using the 14 day Flash Glucose Monitoring System
|
Gordon, Ian |
|
|
164 |
C |
p. |
artikel |
25 |
Metformin in COVID-19: A possible role beyond diabetes
|
Sharma, Swati |
|
|
164 |
C |
p. |
artikel |
26 |
Metformin, neutrophils and COVID-19 infection
|
Dalan, Rinkoo |
|
|
164 |
C |
p. |
artikel |
27 |
Nexus of COVID-19 and diabetes pandemics: Global public health lessons
|
Bergman, Michael |
|
|
164 |
C |
p. |
artikel |
28 |
Parallel epidemics, or nearly so: Certainties and uncertainties about SARS-CoV-2 in Italy
|
Gentile, Sandro |
|
|
164 |
C |
p. |
artikel |
29 |
Prevalence of diabetes mellitus in 2019 novel coronavirus: A meta-analysis
|
Wang, Xiang |
|
|
164 |
C |
p. |
artikel |
30 |
Reply to comment on “Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?”
|
Pal, Rimesh |
|
|
164 |
C |
p. |
artikel |
31 |
Response to COVID-19 and diabetes: Can DPP4 inhibition play a role? – GLP-1 might play one too
|
Morin, Nathaniel |
|
|
164 |
C |
p. |
artikel |
32 |
SARS-CoV-2 and diabetes: New challenges for the disease
|
Cristelo, Cecília |
|
|
164 |
C |
p. |
artikel |
33 |
Stroke in the patient with diabetes (part 1) – Epidemiology, etiology, therapy and prognosis
|
Bell, David S.H. |
|
|
164 |
C |
p. |
artikel |
34 |
Stroke in the patient with diabetes (Part 2) – Prevention and the effects of glucose lowering therapies
|
Bell, David S.H. |
|
|
164 |
C |
p. |
artikel |
35 |
The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19
|
Whyte, Martin B. |
|
|
164 |
C |
p. |
artikel |
36 |
The South Asian Health Foundation (UK) guidelines for managing diabetes during Ramadan
|
Hanif, W. |
|
|
164 |
C |
p. |
artikel |
37 |
Type 1 diabetes triggered by covid-19 pandemic: A potential outbreak?
|
Caruso, Paola |
|
|
164 |
C |
p. |
artikel |